Cubist Systematic Strategies’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $132K | Sell |
|
|||||
|
2024
Q4 | $635K | Buy |
|
|||||
|
2024
Q3 | $8.02K | Sell |
|
|||||
|
2024
Q2 | $49.3K | Sell |
|
|||||
|
2024
Q1 | $55.7K | Sell |
|
|||||
|
2023
Q4 | $142K | Buy |
|
|||||
|
2023
Q3 | $295K | Sell |
|
|||||
|
2023
Q2 | $611K | Buy |
|
|||||
|
2023
Q1 | $445K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $128K | Sell |
|
|||||
|
2022
Q2 | $126K | Buy |
|
|||||
|
2022
Q1 | $59K | Sell |
|
|||||
|
2021
Q4 | $306K | Buy |
|
|||||
|
2021
Q3 | $342K | Sell |
|
|||||
|
2021
Q2 | $935K | Sell |
|
|||||
|
2021
Q1 | $1.62M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $11K | Sell |
|
|||||
|
2019
Q2 | $24K | Sell |
|
|||||
|
2019
Q1 | $127K | Sell |
|
|||||
|
2018
Q4 | $636K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $146K | Buy |
|
|||||
|
2017
Q4 | $33K | Sell |
|
|||||
|
2017
Q3 | $142K | Buy |
|